Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 1998, p. 2542-2547, Vol. 36, No. 9
Department of Arctic Veterinary Medicine,
Received 20 October 1997/Returned for modification 15 April
1998/Accepted 4 June 1998
Orthopoxviruses are being increasingly used as live recombinant
vectors for vaccination against numerous infectious diseases in humans,
domestic animals, and wildlife. For risk assessments and surveillance,
information about the occurrence, distribution and ecology of
orthopoxviruses in western Europe is important but has mainly been
based on serological investigations. We have examined kidneys, lungs,
spleens, and livers of Norwegian small rodents and common shrews
(Sorex araneus) for the presence of orthopoxvirus DNA
sequences by PCR with primers complementary to the viral thymidine
kinase (TK) gene. PCR amplicons were verified as orthopoxvirus specific
by hybridization with a vaccinia virus TK-specific probe. A total of
347 animals (1,388 organs) from eight locations in different parts of
Norway, collected at different times of the year during 1993 to 1995, were examined. Fifty-two animals (15%) from five locations, up to
1,600 km apart, carried orthopoxvirus DNA in one or more of their
organs, most frequently in the lungs. These included 9 of 68 (13%)
bank voles (Clethrionomys glareolus), 4 of 13 (31%)
gray-sided voles (Clethrionomys rufocanus), 3 of 11 (27%)
northern red-backed voles (Clethrionomys rutilus), 16 of 76 (21%) wood mice (Apodemus sylvaticus), and 20 of 157 (13%) common shrews. The previous isolation of cowpox virus from two
clinical cases of infection (human and feline) at two of the locations
investigated suggests that the viruses detected are cowpox and that
some of the virus-carrying small mammalian species should be included
among the cowpox virus natural reservoir hosts in Scandinavia and
western Europe.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Naturally Occurring Orthopoxviruses: Potential for
Recombination with Vaccine Vectors
*
Corresponding author. Mailing address: Department of
Virology, Institute of Medical Biology, University of Tromsø, N-9037 Tromsø, Norway. Phone: (47) 77644621. Fax: (47) 77645350. E-mail: terjet{at}fagmed.uit.no.
Journal of Clinical Microbiology, September 1998, p. 2542-2547, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»